NUMD Nu-Med Plus, Inc.
NUMD financial statements, revenue, balance sheet, cash flow, and SEC filings
Showing 3 of 14 annual and 0 of 56 quarterly periods.
Full history available with a free account or via API.
▼ Company Profile
Filer Category
Non-accelerated filer<br>Smaller reporting company
Entity Type
Operating
Public Float
$3.24M (Jun 2025)
Industry (SIC)
3841 Surgical & Medical Instruments & Apparatus
Incorporated
UT
Fiscal Year End
December (1231)
Phone
631-403-4337
EIN
453672530
Headquarters
PORT JEFFERSON, NY, 11777
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
▼ Key Metrics (TTM)
As of Jun 30, 2025Financials
Revenue
-
Net Income
$-60.83K
Total Assets
-
Total Equity
$-246.69K
Total Debt
-
Free Cash Flow
-
Ratios
Return on Equity
24.7%
Sources and calculation details
Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.
Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.
Annual (FY)
Quarterly 🔒
Chart 🔒
| Metric | FY2025 📄 | FY2024 📄 | FY2023 📄 |
|---|---|---|---|
| Income Statement | |||
| REVENUE | |||
| OPERATING EXPENSES | |||
| SG&A Expense | $23.12K | $34.32K | $27.56K |
| Operating Income | $-48.96K | $-63.33K | $-120.53K |
| NON-OPERATING INCOME / EXPENSE | |||
| Other Income/Expense | $-7.23K | $-5.01K | $-5.00K |
| Pretax Income | $-56.18K | $-68.35K | $-125.53K |
| Net Income | $-56.18K | $-68.35K | $-125.53K |
| PER SHARE & SUPPLEMENTAL | |||
| Diluted EPS | $0.00 | $0.00 | $0.00 |
| Diluted Shares | 83.55M | 83.55M | 81.67M |
| EBITDA | $-48.96K | $-63.33K | $-120.53K |
| Depreciation & Amortization | $0 | $0 | $0 |
| Balance Sheet | |||
| ASSETS | |||
| Cash & Equivalents | $661 | $2.37K | $6.81K |
| Other Current Assets | $7.25K | $7.00K | $6.65K |
| Current Assets | $7.91K | $9.37K | $13.46K |
| Noncurrent Assets | $0 | $0 | $0 |
| Total Assets | $7.91K | $9.37K | $13.46K |
| LIABILITIES | |||
| Accounts Payable | $48.20K | $43.04K | $8.09K |
| Current Liabilities | $279.19K | $224.47K | $160.21K |
| Noncurrent Liabilities | $0 | $0 | $0 |
| Total Liabilities | $279.19K | $224.47K | $160.21K |
| EQUITY | |||
| Common Stock | $83.55K | $83.55K | $83.55K |
| Additional Paid-in Capital | $9.59M | $9.59M | $9.59M |
| Retained Earnings | $-9.95M | $-9.89M | $-9.82M |
| Total Equity | $-271.28K | $-215.10K | $-146.75K |
| Total Liabilities & Equity | $7.91K | $9.37K | $13.46K |
| SUPPLEMENTAL | |||
| Shares Outstanding | 83.55M | 83.55M | 83.55M |
| Check: A − (L + E + NCI) | - | - | - |
| Cash Flow Statement | |||
| Cash from Operations | $-47.98K | $-4.43K | $-66.39K |
| Capital Expenditures | - | - | - |
| Cash from Investing | - | - | - |
| Cash from Financing | $46.27K | - | - |
| Free Cash Flow | - | - | - |
| Beginning Cash (CFS) | $2.37K | $6.81K | - |
| Net Change in Cash | - | - | - |
| Effect of FX on Cash | - | - | - |
| Calculated Ending Cash | - | - | - |
| Cash per BS | $661 | $2.37K | $6.81K |
| Cash scope difference (CFS − BS) | - | - | - |
| Cash per CFS | $661 | $2.37K | $6.81K |
Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.
Create Free Account Log In🔒
Quarterly data and charts require a free account
Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.
▼ Frequently Asked Questions
Is Nu-Med Plus, Inc. profitable?
No. Nu-Med Plus, Inc. reported $-60.83K in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.
Fundamentals Hub